WallStSmart
SGHT

Sight Sciences Inc

NASDAQ: SGHT · HEALTHCARE · MEDICAL DEVICES

$4.09
+3.02% today

Updated 2026-04-30

Market cap
$237.20M
P/E ratio
P/S ratio
3.07x
EPS (TTM)
$-0.74
Dividend yield
52W range
$3 – $9
Volume
0.4M

Sight Sciences Inc (SGHT) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
+24.4%
Last 4 quarters
Revenue YoY growth
+6.9%
Most recent quarter
EPS YoY growth
+65.2%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-7.9%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-31.4%
2026-03-05
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-05$-0.08+47.7%$5.41$3.71-31.4%
2025-11-06$-0.16+38.5%$5.03$5.82+15.7%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.15$-0.08+47.7%$20.39M+6.9%
2025-09-30$-0.26$-0.16+38.5%$19.91M-1.2%
2025-06-30$-0.26$-0.23+11.5%$19.56M-8.5%
2025-03-31$-0.28$-0.28+0.0%$17.51M-9.1%
2024-12-31$-0.18$-0.23-30.7%$19.07M+1.7%
2024-09-30$-0.21$-0.22-4.8%$20.16M+0.7%
2024-06-30$-0.30$-0.25+16.7%$21.37M-9.0%
2024-03-31$-0.28$-0.33-17.9%$19.27M+2.3%
2023-12-31$-0.32$-0.22+31.3%$18.75M
2023-09-30$-0.32$-0.27+15.6%$20.01M
2023-06-30$-0.34$-0.30+11.8%$23.47M
2023-03-31$-0.39$-0.35+10.3%$18.82M

Frequently asked questions

Has Sight Sciences Inc beaten earnings estimates?
Sight Sciences Inc has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of +24.4% over the last 4 quarters.
How does SGHT stock react to earnings?
SGHT stock has moved an average of -7.9% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is Sight Sciences Inc's revenue growth rate?
Sight Sciences Inc reported year-over-year revenue growth of +6.9% in its most recent quarter, with EPS growing +65.2% year-over-year.